IkB RPS6KA2 Method for screening anti-cancer agents comprising detecting interactions of IkB and RPS6KA2

摘要

The present invention relates to a method for screening cancer therapies through interaction of IkB and RPS6KA2. More particularly, the present invention relates to a binding inhibitor compound of IkB and RPS6KA2, and a composition for preventing and treating cancer comprising the compound as an active ingredient. The present invention is effective in that it can screen cancer therapeutic agents at a molecular level and can understand the action of therapeutic agents through intermolecular interactions.;